{"id":"https://openalex.org/W7225410248","doi":"https://doi.org/10.5281/zenodo.24003820","title":"Strategic Product Portfolio Management in the Pharmaceutical Industry: Market Intelligence, Regulatory Insight, and Stage-Gate Decision-Making","display_name":"Strategic Product Portfolio Management in the Pharmaceutical Industry: Market Intelligence, Regulatory Insight, and Stage-Gate Decision-Making","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225410248","doi":"https://doi.org/10.5281/zenodo.24003820"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.24003820","doi":"https://doi.org/10.5281/zenodo.24003820","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24003820","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.24003820","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160032494","display_name":"Anvi Tripathi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153931","display_name":"DY Patil Deemed to be University","ror":"https://ror.org/045qb5273","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210153931"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Anvi Tripathi","raw_affiliation_strings":["D Y Patil University, Nerul"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D Y Patil University, Nerul","institution_ids":["https://openalex.org/I4210153931"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5160032494"],"corresponding_institution_ids":["https://openalex.org/I4210153931"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14306","display_name":"Technology Assessment and Management","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10856","display_name":"Intellectual Property and Patents","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/product-portfolio-management","display_name":"product portfolio management","score":0.8799999952316284},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.9340000152587891},{"id":"https://openalex.org/keywords/stage-gate-process","display_name":"stage-gate process","score":0.7350000143051147},{"id":"https://openalex.org/keywords/market-intelligence","display_name":"market intelligence","score":0.7829999923706055},{"id":"https://openalex.org/keywords/regulatory-intelligence","display_name":"regulatory intelligence","score":0.9660000205039978},{"id":"https://openalex.org/keywords/fda-orange-book","display_name":"FDA Orange Book","score":0.8009999990463257},{"id":"https://openalex.org/keywords/active-pharmaceutical-ingredients","display_name":"active pharmaceutical ingredients","score":0.6790000200271606},{"id":"https://openalex.org/keywords/product-selection-criteria","display_name":"product selection criteria","score":0.5490000247955322},{"id":"https://openalex.org/keywords/patent-expiration","display_name":"patent expiry","score":0.847000002861023},{"id":"https://openalex.org/keywords/regulatory-pathways","display_name":"regulatory pathways","score":0.5080000162124634},{"id":"https://openalex.org/keywords/go-no-go-decisions","display_name":"go/no-go decisions","score":0.7120000123977661},{"id":"https://openalex.org/keywords/product-life-cycle","display_name":"product life cycle","score":0.6470000147819519},{"id":"https://openalex.org/keywords/intellectual-property","display_name":"intellectual property","score":0.6000000238418579},{"id":"https://openalex.org/keywords/drug-pipeline","display_name":"drug development pipeline","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6805999875068665},{"id":"https://openalex.org/C74510933","wikidata":"https://www.wikidata.org/wiki/Q1936145","display_name":"Project portfolio management","level":3,"score":0.6173999905586243},{"id":"https://openalex.org/C2780821815","wikidata":"https://www.wikidata.org/wiki/Q5340806","display_name":"Portfolio","level":2,"score":0.6008999943733215},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.5634999871253967},{"id":"https://openalex.org/C180916674","wikidata":"https://www.wikidata.org/wiki/Q3711935","display_name":"Diversification (marketing strategy)","level":2,"score":0.49630001187324524},{"id":"https://openalex.org/C129875596","wikidata":"https://www.wikidata.org/wiki/Q7247753","display_name":"Product cost management","level":4,"score":0.4855000078678131},{"id":"https://openalex.org/C194304873","wikidata":"https://www.wikidata.org/wiki/Q1967338","display_name":"Product lifecycle","level":3,"score":0.4756999909877777},{"id":"https://openalex.org/C2779635493","wikidata":"https://www.wikidata.org/wiki/Q11279702","display_name":"Patent portfolio","level":3,"score":0.4487999975681305},{"id":"https://openalex.org/C73938075","wikidata":"https://www.wikidata.org/wiki/Q2858767","display_name":"Application portfolio management","level":4,"score":0.44699999690055847},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.4284000098705292},{"id":"https://openalex.org/C545102676","wikidata":"https://www.wikidata.org/wiki/Q1780667","display_name":"Product management","level":3,"score":0.4156999886035919},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.4146000146865845},{"id":"https://openalex.org/C179886680","wikidata":"https://www.wikidata.org/wiki/Q5975206","display_name":"IT portfolio management","level":5,"score":0.39500001072883606},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.3695000112056732},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.3343000113964081},{"id":"https://openalex.org/C40700","wikidata":"https://www.wikidata.org/wiki/Q1411783","display_name":"Industrial organization","level":1,"score":0.32989999651908875},{"id":"https://openalex.org/C15952604","wikidata":"https://www.wikidata.org/wiki/Q179012","display_name":"Project management","level":2,"score":0.3012000024318695},{"id":"https://openalex.org/C56739046","wikidata":"https://www.wikidata.org/wiki/Q192060","display_name":"Knowledge management","level":1,"score":0.29440000653266907},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.2816999852657318},{"id":"https://openalex.org/C86275758","wikidata":"https://www.wikidata.org/wiki/Q376657","display_name":"Strategic management","level":2,"score":0.2653000056743622}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.24003820","doi":"https://doi.org/10.5281/zenodo.24003820","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24003820","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.24003821","doi":"https://doi.org/10.5281/zenodo.24003821","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24003821","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.24003820","doi":"https://doi.org/10.5281/zenodo.24003820","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24003820","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2118511931","https://openalex.org/W7225123338","https://openalex.org/W4382877127","https://openalex.org/W230335523","https://openalex.org/W4396912565","https://openalex.org/W650303382","https://openalex.org/W7100196773","https://openalex.org/W2134119232","https://openalex.org/W4226487178","https://openalex.org/W7126207068"],"abstract_inverted_index":{"Product":[0],"Portfolio":[1,130],"Management":[2,131,143],"(PPM)":[3],"is":[4,75,153],"the":[5,31,54,65,78,84,111,126,133],"strategic":[6],"function":[7],"within":[8],"pharmaceutical":[9,36,162],"organizations":[10],"responsible":[11],"for":[12,18],"identifying,":[13],"evaluating,":[14],"and":[15,25,50,56,64,94,125,132,141,159],"prioritizing":[16],"products":[17],"development":[19],"across":[20],"Active":[21],"Pharmaceutical":[22],"Ingredient":[23],"(API)":[24],"finished-dosage-formulation":[26],"businesses.":[27],"This":[28],"review":[29,81,116,146],"synthesizes":[30],"key":[32],"parameters":[33],"that":[34,69,148],"guide":[35],"product":[37,112,163],"selection\u2014market":[38],"volume,":[39],"sales":[40],"value,":[41],"growth":[42],"potential,":[43],"competitive":[44],"landscape,":[45],"patent":[46],"expiry,":[47],"regulatory":[48,57],"pathway,":[49],"manufacturing":[51],"feasibility\u2014and":[52],"examines":[53],"commercial":[55],"intelligence":[58],"platforms,":[59],"such":[60],"as":[61,121],"IQVIA,":[62],"Cortellis,":[63],"FDA":[66],"Orange":[67],"Book,":[68],"inform":[70],"these":[71],"decisions.":[72],"Particular":[73],"attention":[74],"given":[76],"to":[77,102,155],"structured":[79],"stage-gate":[80],"process":[82],"comprising":[83],"Project":[85,88,91,95,142],"Initiation":[86],"Form,":[87,90,93,97],"Review":[89],"Completion":[92],"Termination":[96],"which":[98],"enables":[99],"cross-functional":[100],"teams":[101],"make":[103],"evidence-based":[104],"go/no-go":[105],"decisions":[106],"at":[107],"defined":[108],"milestones":[109],"throughout":[110],"life":[113],"cycle.":[114],"The":[115,145],"also":[117],"considers":[118],"dosage-form":[119],"diversification":[120],"a":[122,157],"portfolio":[123,151],"strategy":[124],"collaborative":[127],"relationship":[128],"between":[129],"Intellectual":[134],"Property,":[135],"Regulatory":[136],"Affairs,":[137],"Research":[138],"&":[139],"Development,":[140],"functions.":[144],"concludes":[147],"disciplined,":[149],"data-driven":[150],"management":[152],"central":[154],"building":[156],"sustainable":[158],"commercially":[160],"viable":[161],"pipeline.":[164]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}